{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:50:28Z","timestamp":1780599028430,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijantimicag.2025.107556","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T19:28:05Z","timestamp":1750447685000},"page":"107556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["No one-size-fits-all approach: Retrospective analysis of efficacy and safety of serum concentrations of continuously administered vancomycin in critically ill adults reveals different target serum concentrations depending on disease severity"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3716-0791","authenticated-orcid":false,"given":"Katrin","family":"Viertel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"van Meegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2496-4432","authenticated-orcid":false,"given":"Thorsten","family":"Annecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4350-0748","authenticated-orcid":false,"given":"Swetlana","family":"Herbrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Mattner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107556_bib0001","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in Intensive Care units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0002","series-title":"Infektionssurveillance im Modul ITS-KISS, Referenzdaten - Berechnungszeitraum: Januar 2018 bis Dezember 2022","year":"2023"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0003","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/sur.2017.282","article-title":"Empiric antibiotics for sepsis","volume":"19","author":"Buckman","year":"2018","journal-title":"Surg Infect"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0004","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.accpm.2018.10.006","article-title":"Understanding the impact of pathophysiological alterations during critical illness on drug pharmacokinetics","volume":"37","author":"Jamal","year":"2018","journal-title":"Anaesthesia, Crit Care Pain Med"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0006","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3390\/pharmaceutics13091378","article-title":"A monocentric retrospective study of AUC\/MIC ratio of vancomycin associated with clinical outcomes and nephrotoxicity in patients with enterococcal infections","volume":"13","author":"Katip","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0007","doi-asserted-by":"crossref","first-page":"773994","DOI":"10.3389\/fphar.2021.773994","article-title":"The thirty-day mortality rate and nephrotoxicity associated with trough serum vancomycin concentrations during treatment of enterococcal infections: a propensity score matching analysis","volume":"12","author":"Katip","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0008","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter","volume":"57","author":"van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0009","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0010","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/CCM.0000000000004326","article-title":"Continuous versus intermittent infusion of Vancomycin and the risk of acute kidney injury in critically ill adults: a systematic review and meta-analysis","volume":"48","author":"Flannery","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107005","article-title":"Serum concentration of continuously administered vancomycin influences efficacy and safety in critically ill adults: a systematic review","volume":"62","author":"Viertel","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0012","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijantimicag.2005.11.009","article-title":"Loading dose of vancomycin in critically ill patients: 15 mg\/kg is a better choice than 500 mg","volume":"27","author":"Mohammedi","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0013","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12871-015-0065-1","article-title":"Evaluation of a protocol for vancomycin administration in critically patients with and without kidney dysfunction","volume":"15","author":"Spadaro","year":"2015","journal-title":"BMC anesthesiology"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0014","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s15010-013-0460-9","article-title":"Development of acute kidney injury during continuous infusion of vancomycin in septic patients","volume":"41","author":"Cianferoni","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2110-5820-1-26","article-title":"Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients","volume":"1","author":"Spapen","year":"2011","journal-title":"Annals of intensive care"},{"issue":"11","key":"10.1016\/j.ijantimicag.2025.107556_bib0016","first-page":"793","article-title":"Vancomycin serum concentration after 48 h of administration: a 3-years survey in an Intensive care unit","volume":"9","author":"Perin","year":"2020","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0017","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0018","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study","volume":"270","author":"Le Gall","year":"1993","journal-title":"Jama"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0019","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl."},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0020","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Criti Care (London, England)"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0021","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl."},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0022","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0023","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0024","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/CCM.0000000000000514","article-title":"Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*","volume":"42","author":"Hanrahan","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/17512433.2019.1621161","article-title":"Antibiotic exposure at the site of infection: principles and assessment of tissue penetration","volume":"12","author":"Jager","year":"2019","journal-title":"Exp Rev Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0026","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40780-025-00416-7","article-title":"Vancomycin dosing design method considering risk factors for nephrotoxicity","volume":"11","author":"Matsuki","year":"2025","journal-title":"Journal of Pharmaceutical Health Care and Sciences"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0027","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13318-017-0456-4","article-title":"Vancomycin dosing and monitoring: critical evaluation of the current practice","volume":"43","author":"Elbarbry","year":"2018","journal-title":"Eur J Drug Metabol Pharmacokinetics"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0028","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1378\/chest.130.4.947","article-title":"Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices","volume":"130","author":"Jeffres","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0029","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0030","first-page":"e804","article-title":"Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients","volume":"16","author":"Leu","year":"2012","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0031","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40560-020-00504-w","article-title":"The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcome","volume":"8","author":"Scharf","year":"2020","journal-title":"J Intens Care"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0032","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(19)32977-0","article-title":"The global burden of chronic kidney disease","volume":"395","author":"Cockwell","year":"2020","journal-title":"THE Lancet"},{"issue":"4","key":"10.1016\/j.ijantimicag.2025.107556_bib0033","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/bcp.16362","article-title":"Systematic review and meta-analysis of vancomycin therapeutic level for treatment of vancomycin-sensitive enterococcal infections","volume":"91","author":"Katip","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0034","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/CCM.0000000000004476","article-title":"Evaluation of vasopressor exposure and mortality in patients with septic shock","volume":"48","author":"Roberts","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0035","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/cc5086","article-title":"Causes of death and determinants of outcome in critically ill patients","volume":"10","author":"Mayr","year":"2006","journal-title":"Crit Care (London, England)"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0036","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400","author":"Ikuta","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0037","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.mayocp.2022.10.013","article-title":"Association of initial and longitudinal changes in C-reactive protein with the risk of cardiovascular disease, cancer, and mortality","volume":"98","author":"Suthahar","year":"2023","journal-title":"Mayo Clin Proceed"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0038","article-title":"Etiologies of extreme leukocytosis","volume":"15","author":"Viner","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0039","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The nephrotoxicity of Vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin Pharmacol Therapeut"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1373\/clinchem.2018.288332","article-title":"Differences between men and women in mortality and the health dimensions of the morbidity process","volume":"65","author":"Crimmins","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0041","first-page":"284","article-title":"Continuous vs. intermittent vancomycin therapy for gram-positive infections not caused by methicillin-resistant Staphylococcus aureus","volume":"82","author":"Duszynska","year":"2016","journal-title":"Minerva anestesiologica"},{"issue":"12","key":"10.1016\/j.ijantimicag.2025.107556_bib0042","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/ajhp\/zxae317","volume":"82","author":"St Peter","year":"2025","journal-title":"Am J Health-System Pharm"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0043","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00134-024-07387-7","article-title":"Contemporary management of aneurysmal subarachnoid haemorrhage. An update for the intensivist","volume":"50","author":"Robba","year":"2024","journal-title":"Intens Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0044","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00384-018-3025-7","article-title":"Damage control surgery in perforated diverticulitis: ongoing peritonitis at second surgery predicts a worse outcome","volume":"33","author":"Sohn","year":"2018","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ijantimicag.2025.107556_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11318140-000000000-00000","article-title":"Augmented renal clearance: implications for antibacterial dosing in the critically ill","volume":"49","author":"Udy","year":"2010","journal-title":"Clin Pharmacokinetics"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792500113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792500113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:48:42Z","timestamp":1758124122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485792500113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S092485792500113X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107556","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.26.24319482","asserted-by":"object"}]},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No one-size-fits-all approach: Retrospective analysis of efficacy and safety of serum concentrations of continuously administered vancomycin in critically ill adults reveals different target serum concentrations depending on disease severity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107556"}}